Meeder Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.83K | Buy |
|
|||||
|
2025
Q2 | $1.98K | Sell |
|
|||||
|
2025
Q1 | $5.25K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $3K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1K | Sell |
|
|||||
|
2021
Q2 | $3K | Buy |
|
|||||
|
2021
Q1 | $2K | Buy |
|
|||||
|
2020
Q4 | $0 | Sell |
|
|||||
|
2020
Q3 | $159K | Buy |
|
|||||
|
2020
Q2 | $0 | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $8K | Buy |
|
|||||
|
2018
Q3 | $7K | Sell |
|
|||||
|
2018
Q2 | $23K | Sell |
|
|||||
|
2018
Q1 | $33K | Sell |
|
|||||
|
2017
Q4 | $43K | Buy |
|
|||||
|
2017
Q3 | $17K | Buy |
|
|||||
|
2017
Q2 | $2K | Buy |
|
|||||
|
2017
Q1 | $2K | Buy |
|